105 related articles for article (PubMed ID: 32412070)
1. Assessment of Oncology Practice Billing Claims for Supplementing Chemotherapy: A Pilot Study in the Georgia SEER Cancer Registry.
Howlader N; Ward KC; Warren JL; Campbell DS; Coyle L; Mariotto AB
J Natl Cancer Inst Monogr; 2020 May; 2020(55):82-88. PubMed ID: 32412070
[TBL] [Abstract][Full Text] [Related]
2. Utility of the SEER-Medicare data to identify chemotherapy use.
Warren JL; Harlan LC; Fahey A; Virnig BA; Freeman JL; Klabunde CN; Cooper GS; Knopf KB
Med Care; 2002 Aug; 40(8 Suppl):IV-55-61. PubMed ID: 12187169
[TBL] [Abstract][Full Text] [Related]
3. Comparison of SEER Treatment Data With Medicare Claims.
Noone AM; Lund JL; Mariotto A; Cronin K; McNeel T; Deapen D; Warren JL
Med Care; 2016 Sep; 54(9):e55-64. PubMed ID: 24638121
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Completeness of Managed Care Data to Identify Cancer Diagnoses and Treatments for Patients in the SEER-Medicare Data.
Warren JL; Parsons HM; Mariotto AB; Boyd E; Enewold L
Med Care; 2023 Dec; 61(12):846-857. PubMed ID: 37796197
[TBL] [Abstract][Full Text] [Related]
5. Can Medicare billing claims data be used to assess mammography utilization among women ages 65 and older?
Smith-Bindman R; Quale C; Chu PW; Rosenberg R; Kerlikowske K
Med Care; 2006 May; 44(5):463-70. PubMed ID: 16641665
[TBL] [Abstract][Full Text] [Related]
6. Construct validity of medicare chemotherapy claims: the case of 5FU.
Lamont EB; Lauderdale DS; Schilsky RL; Christakis NA
Med Care; 2002 Mar; 40(3):201-11. PubMed ID: 11880793
[TBL] [Abstract][Full Text] [Related]
7. Muddy water? Variation in reporting receipt of breast cancer radiation therapy by population-based tumor registries.
Walker GV; Giordano SH; Williams M; Jiang J; Niu J; MacKinnon J; Anderson P; Wohler B; Sinclair AH; Boscoe FP; Schymura MJ; Buchholz TA; Smith BD
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):686-93. PubMed ID: 23773392
[TBL] [Abstract][Full Text] [Related]
8. Identifying specific chemotherapeutic agents in Medicare data: a validation study.
Lund JL; Stürmer T; Harlan LC; Sanoff HK; Sandler RS; Brookhart MA; Warren JL
Med Care; 2013 May; 51(5):e27-34. PubMed ID: 22080337
[TBL] [Abstract][Full Text] [Related]
9. The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program.
Healy MA; Morris AM; Abrahamse P; Ward KC; Kato I; Veenstra CM
BMC Cancer; 2018 Apr; 18(1):481. PubMed ID: 29703172
[TBL] [Abstract][Full Text] [Related]
10. Mammography use, breast cancer stage at diagnosis, and survival among older women.
McCarthy EP; Burns RB; Freund KM; Ash AS; Shwartz M; Marwill SL; Moskowitz MA
J Am Geriatr Soc; 2000 Oct; 48(10):1226-33. PubMed ID: 11037009
[TBL] [Abstract][Full Text] [Related]
11. Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment.
Cooper GS; Yuan Z; Stange KC; Dennis LK; Amini SB; Rimm AA
Med Care; 2000 Apr; 38(4):411-21. PubMed ID: 10752973
[TBL] [Abstract][Full Text] [Related]
12. Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era.
Morton LM; Dores GM; Schonfeld SJ; Linet MS; Sigel BS; Lam CJK; Tucker MA; Curtis RE
JAMA Oncol; 2019 Mar; 5(3):318-325. PubMed ID: 30570657
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis date agreement between SEER and Medicare claims data: impact on treatment.
Lin CC; Virgo KS
Med Care; 2014 Jan; 52(1):32-7. PubMed ID: 24322987
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Reliability and Correlations of Quality Measures in Cancer Care.
Keating NL; Cleveland JLF; Wright AA; Brooks GA; Meneades L; Riedel L; Zubizarreta JR; Landrum MB
JAMA Netw Open; 2021 Mar; 4(3):e212474. PubMed ID: 33749769
[TBL] [Abstract][Full Text] [Related]
15. Variation in geographic access to chemotherapy by definitions of providers and service locations: a population-based observational study.
Schroeder MC; Chapman CG; Nattinger MC; Halfdanarson TR; Abu-Hejleh T; Tien YY; Brooks JM
BMC Health Serv Res; 2016 Jul; 16():274. PubMed ID: 27430623
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data.
Gold HT; Do HT
Health Serv Res; 2007 Oct; 42(5):2056-69. PubMed ID: 17850533
[TBL] [Abstract][Full Text] [Related]
17. Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer.
Du X; Freeman JL; Warren JL; Nattinger AB; Zhang D; Goodwin JS
Med Care; 2000 Jul; 38(7):719-27. PubMed ID: 10901355
[TBL] [Abstract][Full Text] [Related]
18. Intensity modulated radiation therapy following lumpectomy in early-stage breast cancer: Patterns of use and cost consequences among Medicare beneficiaries.
Halasz LM; Patel SA; McDougall JA; Fedorenko C; Sun Q; Goulart BHL; Roth JA
PLoS One; 2019; 14(9):e0222904. PubMed ID: 31568536
[TBL] [Abstract][Full Text] [Related]
19. Algorithm to Identify Incident Epithelial Ovarian Cancer Cases Using Claims Data.
Huepenbecker SP; Zhao H; Sun CC; Fu S; He W; Giordano SH; Meyer LA
JCO Clin Cancer Inform; 2022 Mar; 6():e2100187. PubMed ID: 35297648
[TBL] [Abstract][Full Text] [Related]
20. Validation of a Population-Based Data Source to Examine National Cancer Clinical Trial Participation.
Green AK; Tabatabai SM; Bai X; Mishra Meza A; Lesny AM; Aghajanian C; Landgren O; Riely GJ; Sabbatini P; Salner A; Lipkin S; Ip A; Bach PB; Begg CB; Mailankody S; Lipitz-Snyderman A
JAMA Netw Open; 2022 Mar; 5(3):e223687. PubMed ID: 35315914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]